Can GLP-1 receptor agonist Ozempic (semaglutide) cause bright red blood per rectum, and how should it be managed?

Bright Red Blood with Bowel Movements on Ozempic

Ozempic (semaglutide) does not directly cause bright red rectal bleeding, but you must urgently evaluate this patient for standard causes of hematochezia—hemorrhoids, anal fissures, or more serious colonic pathology—while being aware that GLP-1 agonists can cause severe gastrointestinal complications including constipation, which may secondarily lead to bleeding.

Immediate Clinical Approach

The FDA label for Ozempic does not list rectal bleeding as a recognized adverse effect 1. However, the drug causes significant gastrointestinal effects that could indirectly contribute to bleeding:

Direct GI Effects of Semaglutide

• Constipation is a well-documented adverse effect that could lead to straining and subsequent hemorrhoidal bleeding or anal fissures 2
• Semaglutide has the highest risk among GLP-1 agonists for constipation (ROR 6.17) 2
• Severe GI complications including bowel obstruction and eosinophilic duodenitis have been reported 3, 4

Evaluation Protocol

Do not assume hemorrhoids. Per AGA guidelines, bright red rectal bleeding requires 5:

1. Minimum workup: Anoscopy AND flexible sigmoidoscopy for all patients with bright red rectal bleeding
2. Full colonoscopy indicated if:
   • Bleeding pattern atypical for hemorrhoids
   • No source found on anorectal exam
   • Patient has risk factors for colonic neoplasia
   • Patient age and comorbidities warrant complete evaluation

Key examination findings to document:

• External inspection for thrombosed external hemorrhoids, anal fissures (look with anal eversion using opposing thumb traction), perianal abscess, or fistula
• Anoscopy with adequate lighting for internal hemorrhoids and rectal mucosal prolapse
• Presence of postdefecatory pain (suggests fissure rather than hemorrhoids)
• Stool consistency and straining history

Critical Pitfall

Hemorrhoids do NOT cause positive fecal occult blood tests 5. If guaiac positive, the colon must be fully evaluated regardless of visible hemorrhoids.

Management Algorithm

If Hemorrhoids/Fissure Confirmed:

1. Continue Ozempic if GI symptoms are tolerable
2. Aggressively manage constipation:
   • Increase fiber and hydration
   • Consider stool softeners
   • Monitor for worsening GI symptoms

If Severe GI Symptoms Present:

Watch for red flags requiring Ozempic discontinuation 1:

• Persistent severe abdominal pain (pancreatitis concern)
• Severe nausea, vomiting, or diarrhea leading to dehydration (acute kidney injury risk)
• Signs of bowel obstruction 3, 4

If No Source Found or Atypical Features:

1. Proceed to colonoscopy before attributing bleeding to medication
2. Consider rare GLP-1 complications: intestinal ischemia 6, eosinophilic enteritis 4

Context on GLP-1 GI Effects

Semaglutide causes the highest rate of GI adverse events among GLP-1 agonists, with most occurring within the first month 2. While nausea, vomiting, and diarrhea are most common, constipation affects a significant proportion and typically manifests as mild-to-moderate and transient 7. However, severe cases including subocclusive ileus have been documented 3.

The bleeding itself is not a direct drug effect—it represents mechanical trauma from constipation-induced straining or unrelated pathology that requires standard evaluation per gastroenterology guidelines 5.